Skip to main navigation menu Skip to main content Skip to site footer
DOI:
https://doi.org/10.57187/3824

Original article

Vol. 156 No. 9 (2026)

Implementation of Activity-Based Funding and Patient Trajectory Managers’ contributions to financial indicators and care in a Swiss General Internal Medicine Department: a retrospective study

Cite this as:
Swiss Med Wkly. 2026;156:3824
Published
30.09.2026

Summary

BACKGROUND: In 2012, Switzerland introduced a new activity-based funding system (SwissDRG). In 2014, Geneva University Hospitals also introduced a new staff role, Patient Trajectory Manager (PTM), aimed at optimising patient care trajectories, hospital length of stay (LOS) and clinical documentation. The objective of the present study was to analyse the impact of the SwissDRG on quality and efficiency of care in our division. We also analysed the impact of the implementation of Patient Trajectory Managers on efficiency.

METHODS: We analysed 59,621 hospitalisations between 2007 and 2019 using statistical description with an ARIMA model, complemented by interrupted time-series analysis based on SARIMA intervention models. The primary outcome was LOS; secondary outcomes included average length of stay (ALOS), Cost Weight, discharge destination, difference vs theoretical ALOS, readmissions and mortality.

RESULTS: Following SwissDRG implementation, median LOS decreased from 10 days (2007–2011) to 8 days (2012–2019; p <0.001), with a higher proportion of patients discharged home (70.2% vs 75.4%, p <0.001). Interrupted time-series analyses confirmed a significant immediate reduction in LOS at the time of SwissDRG introduction, followed by a sustained downward trend. No significant effects were observed on 18-day readmissions or in-hospital mortality. After the introduction of PTMs, LOS continued to decrease and remained below predicted trajectories derived from pre-PTM trends, but interrupted time-series analyses did not identify an additional significant abrupt level reduction. However, significant post-intervention slope changes were observed for LOS-related efficiency indicators, indicating a sustained monthly reduction over time rather than an immediate effect. The period after PTM implementation was also associated with a reduced gap between observed and theoretical DRG LOS and fewer LOS upper-outliers, without adverse effects on readmissions or mortality.

CONCLUSION: There was a significant decrease in LOS across the three successive periods of observation. The introduction of activity-based funding through SwissDRG was associated with a major and immediate significant reduction in hospital LOS. However, subsequent organisational interventions through the implementation of Patient Trajectory Managers did not produce an additional causal level significant reduction in LOS but was associated with sustained improvements in efficiency-related trends, optimisation of DRG-related performance and stabilisation of care processes over time, without compromising patient outcomes.

References

  1. 1. Busse R, Geissler A, Quentin W, Wiley M. Diagnosis related groups in Europe: Moving towards transparency, efficiency, and quality in hospitals. European Observatory on Health Systems and Policies series.. Open Universitiy Press; 2011.
  2. 2. Duckett SJ, T, Hatcher J, Richards H, Murphy K. The Why, the What and the How of Activity-Based Funding in Canada: A Resource for Health System Funders and Hospital Managers. In: CIfH I, editor. 2013.
  3. 3. Mayes R. The Origins, Development, and Passage of Medicare's Revolutionary Prospective Payment System. Journal of the History of Medicine and Allied Sciences. 2006;62(1):21-55.
  4. 4. Aragon MJCM, Kreif N. The long-run effects of diagnosis related group payment on hospital lengths of stay in a publicly funded health care system: Evidence from 15 years of micro data. Health Economics. 2022;31:956-72.
  5. 5. Meng ZHW, Cai Y, Liu J, Wu H. The effects of DRGs-based payment compared with cost-based payment on inpatient healthcare utilization: A systematic review and meta-analysis. Health Policy. 2020;124(4):359-67.
  6. 6. Al-Khalil OVF, Senn O, Rosemann T, Di Gangi S. Effects of a DRG-based hospital reimbursement on the health care utilization and costs in Swiss primary care: A retrospective "quasi-experimental" analysis. Plos One. 2020;15(10):e0241179.
  7. 7. Palmer KS, Agoritsas T, Martin D, Scott T, Mulla SM, Miller AP. Activity-based funding of hospitals and its impact on mortality, readmission, discharge destination, severity of illness, and volume of care: a systematic review and meta-analysis. PLoS One. 2014;9(10):e109975.
  8. 8. Kone I, Maria Zimmermann B, Nordstrom K, Simone Elger B, Wangmo T. A scoping review of empirical evidence on the impacts of the DRG introduction in Germany and Switzerland. Int J Health Plann Manage. 2019;34(1):56-70.
  9. 9. Statistiques des hôpitaux en 2018- Stagnation des coûts dans le domaine stationnaire des hôpitaux.
  10. 10. Wu Y, Fung H, Shum HM, Zhao S, Wong EL, Chong KC. Evaluation of Length of Stay, Care Volume, In-Hospital Mortality, and Emergency Readmission Rate Associated With Use of Diagnosis-Related Groups for Internal Resource Allocation in Public Hospitals in Hong Kong. JAMA Netw Open. 2022;5(2):e2145685.
  11. 11. Li J, Peng M, Deng S, Wu J, Zhou W. The impact of diagnosis-related groups on medical costs, service efficiency, and healthcare quality in Meishan, China: An interrupted time series analysis. PLoS One. 2025;20(5):e0325041.
  12. 12. Feng X, Cheng L, Wei H. Study on the cost-control effect of diagnosis-related groups based on meta-analysis. Medicine (Baltimore). 2024;103(37):e39421.
  13. 13. Wang Z, Li L, Cui Y. A study on the impact of DRG payment on physicians' prescribing behavior in China: a case study of a healthcare consortium in J City. Front Public Health. 2025;13:1532622.
  14. 14. OFSP. Loi fédéral sur l'assurance-maladie (LAMal), art. 49 et 49a. In: Santé. 2022:27-9.
  15. 15. SwissDRG. Soins somatiques aigus 2022 [Internet]. SwissDRG; 2022. Available from: https://www.swissdrg.org/fr/somatique-aigue/swissdrg
  16. 16. Tipton K, LB, Mull N, Siddique S, Greysen S, Lane-Fall M, et al. Interventions To Decrease Hospital Length of Stay. 2021.
  17. 17. Kainzinger F, RC, Pietrek K, Müller-Nordhorn J, Willich S. Optimization of hospital stay through length-of-stay-oriented case management: an empirical study. Journal of Public Helath. 2009;17:395-400.
  18. 18. Box GEP, Jenkins GM, Reinsel GC, Ljung GM. Time Series Analysis: Forecasting and Control. Hoboken (NJ): .
  19. 19. Box GEP, Tiao GC. Intervention analysis with applications to economic and environmental problems. Journal of the American Statistical Association. 1975;70(349):70-9.
  20. 20. Kutz A, Koch D, Haubitz S, Conca A, Baechli C, Regez K. Association of Interprofessional Discharge Planning Using an Electronic Health Record Tool With Hospital Length of Stay Among Patients with Multimorbidity: A Nonrandomized Controlled Trial. JAMA Netw Open. 2022;5(9):e2233667.

Most read articles by the same author(s)